CD8A and neoplasm: In summary, tumor recognition, in cooperation with monocyte-derived IL-18, induce the expression of PD-L1 on NK cells, resulting in an enrichment in PD-L1hi NK cells that in turn limit CD8+ T cell proliferation in a PD-L1-dependent manner.